MAIA Biotechnology, Inc.
MAIA- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001878313
In the last 90 days, MAIA Biotechnology, Inc. insiders filed 7 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q3 2026, worth $14.2M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 18, 2026
- $80.3M
- Insider buysLast 90 days, $552.3K in total
- 7
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ3 2026, +7 vs. previous quarter
- 43
- 13F valueReported value at the end of Q3 2026
- $14.2M
- Superinvestors holdingAt the end of Q3 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- –
- No comparable prior period
- Net income, FY2025
- -$22.4M
- No comparable prior period
- Free cash flow, FY2025
- –
- No comparable prior period
- Revenue, Q3 FY2026
- –
- No comparable prior period
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 2.45M
- Shares sold short
- Change
- −70.7K
- −2.8% vs. previous
- Days to cover
- 9.02
- At average daily volume
Superinvestors holding MAIA, Q3 2026
Go to the superinvestors tabNo superinvestor reported holding MAIA at the end of Q3 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by MAIA Biotechnology, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2026 (view filing)4:07 PM ET | Nov 13-16 | 4 days | Smith StanDirector | PPurchase | +100.0K | $1.00 | +$100.0K | +6.6%1.62M after | 2 lots |
| Nov 17, 2026 (view filing)4:05 PM ET | Nov 13-16 | 4 days | Vitoc VladChief Executive Officer | PPurchase | +100.0K | $1.00 | +$100.0K | +9.5%1.15M after | 2 lots |
| Sep 15, 2026 (view filing)6:33 AM ET | Sep 14 | 1 day | Vitoc VladChief Executive Officer | PPurchase | +73.0K | $1.37 | +$100.0K | +7.5%1.05M after | |
| Sep 14, 2026 (view filing)9:03 AM ET | Sep 10 | 4 days | Guerrero RamiroDirector | PPurchase | +37.6K | $1.32 | +$49.5K | +5.1%773.3K after | |
| Sep 1, 2026 (view filing)4:16 PM ET | Aug 26-28 | 6 daysLate | Guerrero RamiroDirector | PPurchase | +133.8K | $1.38 | +$184.1K | +22.2%735.7K after | 3 lots |
| Aug 26, 2026 (view filing)7:56 AM ET | Aug 24 | 2 days | Guerrero RamiroDirector | PPurchase | +1.79K | $1.33 | +$2.39K | +0.3%601.9K after | |
| Aug 24, 2026 (view filing)4:09 PM ET | Aug 20 | 4 days | Guerrero RamiroDirector | PPurchase | +11.9K | $1.37 | +$16.3K | +2.0%600.1K after | |
| Jun 2, 2026 (view filing) | Jun 1 | 1 day | Vitoc VladChief Executive Officer | PPurchase | +72.7K | $1.39 | +$101.1K | +8.0%976.1K after | |
| Jun 2, 2026 (view filing) | Jun 1 | 1 day | Smith StanDirector | PPurchase | +75.0K | $1.34 | +$100.5K | +5.2%1.52M after | |
| Jun 2, 2026 (view filing) | Jun 1 | 1 day | Gryaznov SergeiChief Scientific Officer | PPurchase | +2.00K | $1.35 | +$2.70K | +4.5%46.5K after |
Top 10 13F holders, Q3 2026
See all 43 holdersThe largest institutional positions in MAIA Biotechnology, Inc. at the end of Q3 2026; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Solas Capital Management, LLC | 3,030,845 | $3.58M | 2.00% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 2,413,270 | $2.85M | 0.00% | 00.0% | Unchanged |
| Centric Wealth Management | 1,167,070 | $1.27M | 0.19% | +370,347+46.5% | Added |
| 683 Capital Management, LLC | 1,066,666 | $1.26M | 0.12% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 584,401 | $689.8K | 0.00% | +80,021+15.9% | Added |
| Cable Car Capital LLC | 514,583 | $607.2K | 0.18% | 00.0% | Unchanged |
| Bleichroeder LP | 500,000 | $590.0K | 0.06% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 399,100 | $470.9K | 0.00% | −16,600−4.0% | Reduced |
| BlackRock, Inc. | 394,772 | $465.8K | 0.00% | −8,239−2.0% | Reduced |
| Vanguard Fiduciary Trust Co | 336,688 | $397.3K | 0.00% | 00.0% | Unchanged |
Holders of 5% or more of MAIA
See all 2 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of MAIA Biotechnology, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| FGMK Business Holdings, LLC | 13G | 9.99%2.89M shares | New | Mar 3, 20251 filing | Mar 3, 2025 | SEC |
| Vitoc Vlad | 13D/A | 9.66%3.85M shares | – | Feb 14, 20233 filings | Dec 4, 2025 | SEC |